N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients

NCT00780962 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

399

Enrollment

OTHER

Sponsor class

Conditions

Radiocontrast Nephropathy

Interventions

DRUG: N-Acetylcysteine (NAC)
DRUG: 0.9% Sodium-chloride

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]